Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > This man’s credentials on the board... astounding
View:
Post by BankBenjamins on Feb 08, 2021 12:12pm

This man’s credentials on the board... astounding

Number of Founded Organizations 1
CB Rank (Person) 67,651
Choong-Chin Liew was born in Malaysia, educated in Malaysia and Singapore and received his PhD (1967) in pathological chemistry from the University of Toronto, Canada. He was professor in the Department of Laboratory Medicine and Pathobiology there from 1970 until retiring in 2003, and is currently Professor Emeritus (UT) and Visiting Professor of

Medicine at Brigham and Women’s Hospital, Harvard Medical School. Over the course of his teaching career, Professor Liew trained more than two dozen PhD and MSc students and some 50 postdoctoral fellows. He is also a co-founder, director and Chief Scientist of GeneNews Limited, a publicly traded biotechnology company based in Toronto, Canada.

Professor Liew is a pioneer in the emerging field of molecular medicine and globally recognized as a leader in disease-specific genomics research. He has received some 14 Honorary Professorships in universities including The Chinese University of Hong Kong, and Peking University, Beijing. In 2002 he won the Society of Chinese Bioscientists in America (SCBA) Distinguished Scientist Award (Ontario Chapter) and the Makoto Nagano Award for Achievements in Cardiovascular Education, and in 2005 the Nanyang Distinguished Alumni Award. 

To date, he has published more than 300 original scientific papers, abstracts, and monographs. His 1997 landmark publication in Circulation, a pre-eminent U.S. peer reviewed journal, reported his work in cardiovascular genomics. This report is widely acknowledged to represent the most comprehensive analysis of genes expressed in a single human organ. More recently Professor Liew and Dr Victor Dzau, Chancellor for Health Affairs of Duke University, published “Molecular Genetics and Genomics of Heart Failure in Nature Reviews Genetics (2004) and co-edited Cardiovascular Genetics and Genomics for the Cardiologist, published in July 2007 by Blackwell’s, Oxford. 

Currently Professor Liew is leading the research efforts of GeneNews to further develop the Sentinel PrincipleTM, a blood-based diagnostic technology that can identify molecular signatures for virtually any human disease. The Sentinel Principle was recognized in 2006 with the Frost and Sullivan North American Technology Innovation of the Year Award in the field of genetic biomarkers.

Jobs

Number of Current Jobs 1
Choong-Chin Liew is the Co-Founder and Chief Scientist at StageZero Life Sciences.
Comment by Skrit37 on Feb 08, 2021 12:20pm
LOL...on what board?
Comment by BankBenjamins on Feb 08, 2021 12:22pm
StageZero....
Comment by Skrit37 on Feb 08, 2021 12:23pm
oh yea, thats current?
Comment by MarketMoney on Feb 08, 2021 12:24pm
He died https://www.legacy.com/obituaries/thestar/obituary.aspx?n=choong-chin-liew-c-c&pid=193604256&fhid=17733
Comment by Skrit37 on Feb 08, 2021 12:27pm
aww common Marketmoney ...i wanted him to dig himself a bit further into a hole before dropping that!!
Comment by BankBenjamins on Feb 08, 2021 12:27pm
No waayy.... rip. I had no clue!
Comment by LionWhisperer on Feb 08, 2021 12:33pm
This post has been removed in accordance with Community Policy
Comment by BankBenjamins on Feb 08, 2021 12:42pm
All I could say now is that when Aristotle gets realeased within a few weeks, his contributions to the team he broughten to the table will go down in history and memory of him with great success to their work they did to make Aristotle happen.
Comment by LionWhisperer on Feb 08, 2021 12:43pm
This post has been removed in accordance with Community Policy
Comment by BankBenjamins on Feb 08, 2021 12:49pm
We’re getting some nice support with the 1.10 after the jump on Friday’s close
Comment by LionWhisperer on Feb 08, 2021 12:55pm
This post has been removed in accordance with Community Policy
Comment by BankBenjamins on Feb 08, 2021 1:30pm
Mann wish I could buy that many... jeez Ps this is Jeff Brown’s #1 stock pick of the year. Had it confirmed by the top rbc broker at my branch last week when I had some issues with their crappy system. He was surprised I knew without having his subscription. Jeff is a great credible source for insight on upcoming big moves in the market. Predicted 08 stock crash, bitcoin, amazon and many others ...more  
Comment by BankBenjamins on Feb 08, 2021 1:39pm
Just to clarify Jeff Brown is not the stock broker at my branch lmao If you haven’t heard his name before
Comment by Nailbiter1 on Feb 08, 2021 12:52pm
This post has been removed in accordance with Community Policy
Comment by capebretongirl on Feb 08, 2021 12:54pm
Maybe they can order a few Aristotle tests over there to help them out............
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities